Advertisement

Pharmacists' Intervention Strategies

This resource provides practical articles on Cost Management Strategies and links to locate them. These articles are provided to assist pharmacy managers and directors in dealing with the management issues focused on the affordability and accessibility of pharmaceuticals. Current topics covered in this new resource section include pharmacists' intervention strategies, formulary management strategies , population-based strategies , and anti-infective management strategies. Additional strategies will be added periodically to assist managers and directors in managing high-cost issues in pharmacy.

  1. Lee AJ, Boro MS, Knapp KK, Meier JL, Korman NE. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health Syst Pharm. 2002; 59: 2070-77.
  2. Carter BL, Malone DC, Billups SJ, Valuck RJ, et.al. Interpreting the findings of the IMPROVE study: Impact of managed pharmaceutical care on resource utilization and outcomes in Veterans Affairs medical centers. Am J Health Syst Pharm. 2001 Jul 15;58(14):13301337
  3. Nesbit TW, Shermock KM, Bobek MB, Capozzi DL et. Al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacy practice model. Am J Health-Syst Pharm. 2001;58:784-90.
  4. Skledar SJ, Hess MM. Implementation of a drug-use and disease-state management program. Am J Health-Syst Pharm 2000;57(suppl 4):S23-29.
  5. Yanchick JK. Implementation of a drug therapy-monitoring clinic in a primary care setting. Am J Health-Syst Pharm 2000;57(suppl 4):S30–34.
  6. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000 Jun;20(6):609-21
  7. Merenich JA, Lousberg TR, Brennan SH, Calonge NB. Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente experience). Am J Cardiol. 2000 Feb 10; 85(3A):36A-42A.
  8. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
  9. Grabenstein JD, Bonasso J. Health-system pharmacists’ role in immunizing adults against pneumococcal disease and influenza. Am J Health Syst Pharm. 1999 Sep 1; 56(17 Suppl 2):S3-22.
  10. Leape LL, Cullen DJ, Dempsey CM, et al. Pharmacists’ participation on physicians rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-270.
  11. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med 1999;159:1939–45.
  12. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, et.al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999 Oct 25;159(19):2306-9.
  13. Bozek PS; Perdue BE; Bar-Din M; Weidle PJ. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health-Syst Pharm; 1998; 55(Jun 1); 1151-1155.
  14. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-1647
  15. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32(6):636–41.
  16. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs medical center. Pharmacotherapy 1998;18:1103-11.
  17. Boyko WL, Yurkowski PJ, Ivey MF, Armistead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997 Jul 15; 54(14):1591-1595.
  18. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17(1):140–7.
  19. Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld W. E conomic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997;19:113-23.
  20. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy service-1988–1995. Pharmacotherapy 1996; 16:1188–1208.

 
Advertisement